LGALS3 and heart disorder: The intrapericardial infusion of galectin-3 induced cardiac fibrosis, cardiomyocyte hypertrophy and impairment of heart function in rats [44, 45], whereas genetic or pharmacological inhibition of galectin-3 limited the deposition of collagen and prevented cardiac dysfunction in several animal models of heart disease [46].